Home
Ascentage Pharma

Ascentage Pharma Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainascentagepharma.com

Year Founded2009

Employees201 - 500

Annual Revenue$100M - $200M

Ascentage Pharma

Ascentage Pharma (including company regionals)

ascentagepharma.com

See more website traffic and engagement information

Ascentage Pharma Revenue up to June 2026 is 100M - 200M

revenue generated by Ascentage Pharma top domains

Ascentage Pharma top domains revenue over 3 years

Revenue for Ascentage Pharma top domains

ascentagepharma.com100M - 200M

See more with Sales Intelligence

Total visits to Ascentage Pharma's top domains

Understand Ascentage Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ascentagepharma.com5.6K

See more with Sales Intelligence

Avg. visit duration in Ascentage Pharma's top domains

Analyze Ascentage Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ascentagepharma.com00:01:40

See more with Sales Intelligence

Avg. pageviews on Ascentage Pharma's top domains

See how Ascentage Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ascentagepharma.com3.08

See more with Sales Intelligence

Ascentage Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Ascentage Pharma

These are the website technologies, by industry, used by Ascentage Pharma top domains

Mobile (3)

Meta Viewport

Conversion & Analytics (2)

Google Analytics

Multilingual (2)

Multilingual Support

Widget (2)

General Captcha

More Technologies

6

See all

News & Signals from Ascentage Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAscentagepharma received financing of $126M in initial public offering on Jan 1st '25.Ascentage Pharma, a cancer drug developer based in Suzhou, China, on Thursday raised just over $126 million in the first U.S. initial public offering by a biotechnology company this year.

NewsAscentagepharma attends event 43rd Annual J.P. Morgan Healthcare Conference.Ascentage Pharma to present at 43rd Annual J.P. Morgan Healthcare Conference.